𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma

✍ Scribed by Kari Hemminki; Lauri Aaltonen; Xinjun Li


Book ID
102108237
Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
93 KB
Volume
97
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

BACKGROUND

Population‐based data on subsequent neoplasms after women are diagnosed with endometrial and ovarian carcinomas are limited, particularly regarding specific histologic tumor types.

METHODS

The nationwide Swedish Family‐Cancer Database of 10.2 million individuals, which includes 19,128 invasive endometrial carcinomas and 19,440 ovarian carcinomas, was used to calculate standardized incidence ratios (SIRs) and 95% confidence intervals (95% CIs) for second primary carcinomas. SIRs were calculated for specific follow‐up periods. Data on histopathologic types also were used.

RESULTS

An excess of subsequent malignancies after women were diagnosed with endometrial carcinoma was noted at 11 sites. The highest SIRs were recorded for synchronous or metasynchronous ovarian carcinomas (SIR, 55.77; 95% CI, 48.82–63.43) and carcinomas of the small intestines (SIR, 14.71; 95% CI, 4.64–34.59). Primary ovarian carcinoma was followed by an increased risk of developing endometrial carcinoma, and the risks of developing many other malignancies also were increased after women were diagnosed with endometrial carcinoma, including intestinal malignancies, renal cell carcinoma, bladder carcinoma, squamous cell skin carcinoma, connective tissue malignancies, and leukemia. When ovarian endometrioid histology was diagnosed synchronously with primary endometrial carcinoma, the SIR was 140; when endometrial carcinoma was the subsequent neoplasm, the SIR was 87. A small familial component was found in the cooccurrence of endometrial carcinoma and ovarian carcinoma.

CONCLUSIONS

The current data show a strong clustering of endometrial carcinomas and ovarian carcinomas, particularly involving tumors of endometrioid morphology. The patterns of second neoplasms also suggest that hereditary nonpolyposis colorectal carcinoma may contribute to the association between endometrial and ovarian malignancies. Increased risks for connective tissue tumors and leukemia may signal a response to treatment, and an increased risk for squamous cell skin carcinoma may signal a depressed immune function. Cancer 2003;10:2432–9. Β© 2003 American Cancer Society.

DOI 10.1002/cncr.11372


πŸ“œ SIMILAR VOLUMES


The incidence of subsequent endometrial
✍ Katsuyoshi Katase; Yuko Sugiyama; Katsuhiko Hasumi; Masataka Yoshimoto; Fujio Ka πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 76 KB πŸ‘ 2 views

## Background: Tamoxifen commonly is used as adjuvant therapy for all stages of breast carcinoma. however, several studies have suggested an association between the use of tamoxifen in breast carcinoma patients and the subsequent development of endometrial carcinoma. the objective of this study was

Second primary cancers of endometrial ca
✍ Vitune Vongtama; Samuel S. Kurohara; Ahmed O. Badib; John H. Webster πŸ“‚ Article πŸ“… 1970 πŸ› John Wiley and Sons 🌐 English βš– 325 KB πŸ‘ 2 views

Of 984 patients with corpus cancer treated at Roswell Park Memorial Institute (between 1940 and 1960), 116 (11.8%) were found to have second primaries; of these, 47 had breast cancer, 15 skin cancer, 27 other pelvic cancers, 15 abdominal cancer, 3 head and neck cancer, and 3 lymphoma or leukemia. T